Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

142 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Cancer trial results

Recruiting

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

NCT06764485

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Local Institution - 0370 Anaheim, California, United States
  • Moores Cancer Center La Jolla, California, United States
View all 281 locations
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT06842498

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Western Regional Medical Center - City of Hope Phoenix Goodyear Goodyear, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
View all 23 locations
View Trial Details
Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT06629779

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Ironwood Cancer & Research Centers Gilbert, Arizona, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Ironwood Cancer & Research Centers Glendale, Arizona, United States
View all 236 locations
View Trial Details
Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

NCT07213674

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • City of Hope Cancer Center Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
View all 149 locations
View Trial Details
Recruiting

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

NCT05519449

Conditions
Castration Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

NCT06067841

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • Florida Cancer Specialists Sarasota Drug Development Unit Sarasota, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 15 locations
View Trial Details
Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

NCT07545811

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Prisma Health Cancer Institute Greenville, South Carolina, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • SCRI at Mary Crowley Dallas, Texas, United States
View Trial Details

Related conditions